News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business
Friday, March 31, 2023NEC Corporation announced in that it would expand the application of its cuttingedge AI technologies to drug development focusing on advanced therapy as part of enhancing its healthcare business Subsequently in order to advance AIpowered personalize...
Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
Friday, March 31, 2023Confo Therapeutics a leader in the discovery of medicines targeting Gprotein coupled receptors GPCRs today announced that it has entered a collaboration agreement with Daiichi Sankyo TSE for the discovery and development of small molecule agonists a...
Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million
Thursday, March 30, 2023Avadel Pharmaceuticals plc a biopharmaceutical company focused on transforming medicines to transform lives today announced its entry into a royalty agreement with RTW Investments LP and certain of its affiliates RTW for up to million to support the...
RAPT Therapeutics Announces Initiation of Phase 2a Trial of RPT193 in Patients with Moderate-to-Severe Asthma
Thursday, March 30, 2023RAPT Therapeutics Inc a clinicalstage immunologybased therapeutics company focused on discovering developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology today annou...
MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology
Wednesday, March 29, 2023MIMETAS a global leader in human disease modeling announces that it has entered into a strategic partnership with Astellas Pharma Inc a global pharmaceutical company The partnership comprises utilizing MIMETAS comprehensive tumor models to support th...
Neutra’s Strategic Move to Put the Organization in Position to Achieve Its Plans for Growth
Wednesday, March 29, 2023Neutra Corporation an emerging health and wellness research and development company last month announced the execution of a letter of intent to acquire Mercury Clinical Research a privatelyowned site management organization SMO comprised of a network...
Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease
Tuesday, March 28, 2023Revolo Biotherapeutics a company developing therapies that reset the immune system to achieve superior longterm remission for patients with autoimmune and allergic diseases today announced that the last patient has completed the twelveweek Phase a cl...
Amicus Therapeutics Announces European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease
Tuesday, March 28, 2023Amicus Therapeutics a patientdedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases today announced that the European Commission EC has granted approval for Pombiliti cipaglucosidase alfa a...
ACTG Announces Publication of Pivotal Hepatitis C Study in Clinical Infectious Diseases
Monday, March 27, 2023The AIDS Clinical Trials Group ACTG the worlds largest HIV research network is announcing the publication of Perspectives on Adherence from the ACTG MINMON Trial A Minimum Monitoring Approach with Weeks
Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancer
Friday, March 24, 2023Macomics Ltd a leader in macrophage drug discovery announces that it has entered into a worldwide drug discovery collaboration agreement with Ono Pharmaceutical Co Ltd to develop new immunooncology antibody drugs against a novel macrophage target of...
